MIRA Pharmaceuticals, Inc. Common Stock (MIRA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $27.73M
Last updated: Nov 17, 2026 at 11:03 AM ET
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Earnings: Report Dates and Results
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, MIRA Pharmaceuticals, Inc. Common Stock reported EPS of -$0.03. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
MIRA has an expected report date of Mar 29, 2027.
Earnings History
Of the 10 quarters below that had an estimate, MIRA beat 4, missed 5 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 225.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2026 |
| Mar 31, 2026 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2026 |
| Dec 31, 2025 | -$0.14 | -$0.08 | N/A | -78.38% | Miss | N/A | 1 | 1 up, 0 down | Mar 31, 2026 |
| Sep 30, 2025 | -$0.07 | -$0.08 | -$0.08 - -$0.08 | +12.50% | Beat | N/A | 1 | 0 up, 1 down | Nov 13, 2025 |
| Jun 30, 2025 | -$0.09 | -$0.13 | -$0.15 - -$0.11 | +30.77% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.11 | -$0.14 | -$0.15 - -$0.14 | +21.43% | Beat | N/A | 2 | 0 up, 0 down | May 14, 2025 |
| Dec 31, 2024 | -$0.18 | -$0.13 | N/A | -34.62% | Miss | N/A | 2 | 0 up, 1 down | Mar 28, 2025 |
| Sep 30, 2024 | -$0.14 | -$0.15 | -$0.18 - -$0.13 | +6.67% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$0.11 | -$0.11 | -$0.12 - -$0.08 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$0.12 | -$0.10 | N/A | -20.00% | Miss | N/A | 1 | 0 up, 1 down | Apr 1, 2024 |
| Dec 31, 2023 | -$0.37 | -$0.23 | N/A | -60.87% | Miss | N/A | N/A | 0 up, 0 down | Feb 28, 2024 |
| Sep 30, 2023 | -$0.26 | -$0.08 | N/A | -225.00% | Miss | N/A | N/A | N/A | Nov 13, 2023 |
| Jun 30, 2023 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 15, 2023 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.41, after -$0.55 the year before. It was -$0.73 for the year ended Dec 31, 2023, the oldest of the 3 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.41 | N/A |
| Dec 31, 2024 | -$0.55 | N/A |
| Dec 31, 2023 | -$0.73 | N/A |
Frequently Asked Questions About MIRA
When is MIRA Pharmaceuticals, Inc. Common Stock's next earnings date?
MIRA Pharmaceuticals, Inc. Common Stock's next earnings report is expected for Mar 29, 2027.
How often does MIRA beat earnings estimates?
MIRA Pharmaceuticals, Inc. Common Stock beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -7.70%.
MIRA pages: Overview, Earnings, Forecast, Financials, Competitors